Literature DB >> 498416

Uptake of the daunorubicin-DNA complex in cultured fibroblasts.

C Peterson, G Noël, A Zenebergh, A Trouet.   

Abstract

The uptake and fate of the daunorubicin-DNA complex have been studied in cultured rat embryo fibroblasts. 125I-DNA was digested by the cells and appeared as low molecular weight fragments in the incubation medium. Subcellular fractionation of fibroblasts, previously incubated with the complex, showed that daunorubicin was localized to nuclei and lysosomes. At a high incubation concentration (17.5 microM), the accumulation of the free drug exceeded that of the complex. However, at a lower concentration (1.75 microM), the accumulation of the complex was as high as that of the free drug. The results are consistent with an uptake of the complex into cultured rat embryo fibroblasts by endocytosis. However, it cannot be excluded that the complex partly dissociates in the incubation medium, and that daunorubicin and DNA thereafter enter the cells separately.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 498416     DOI: 10.1007/bf00253096

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  17 in total

1.  Tissue fractionation studies. 6. Intracellular distribution patterns of enzymes in rat-liver tissue.

Authors:  C DE DUVE; B C PRESSMAN; R GIANETTO; R WATTIAUX; F APPELMANS
Journal:  Biochem J       Date:  1955-08       Impact factor: 3.857

2.  In vitro iodination of DNA. Maximizing iodination while minimizing degradation; use of buoyant density shifts for DNA-DNA hybrid isolation.

Authors:  J M Orosz; J G Wetmur
Journal:  Biochemistry       Date:  1974-12-31       Impact factor: 3.162

3.  Daunorubicin in the therapy of acute granulocytic leukemia.

Authors:  M Weil; O J Glidewell; C Jacquillat; R Levy; A A Serpick; P H Wiernik; J Cuttner; B Hoogstraten; L Wasserman; R R Ellison; S Gailani; K Brunner; R T Silver; V B Rege; M R Cooper; L Lowenstein; N I Nissen; F Haurani; J Blom; M Boiron; J Bernard; J F Holland
Journal:  Cancer Res       Date:  1973-05       Impact factor: 12.701

4.  Interaction of daunomycin and its derivatives with DNA.

Authors:  F Zunino; R Gambetta; A Di Marco; A Zaccara
Journal:  Biochim Biophys Acta       Date:  1972-09-14

5.  Fate of DNA and its complexes with daunorubicin and adriamycin in rat fibroblasts [proceedings].

Authors:  G Noël; A Trouet
Journal:  Arch Int Physiol Biochim       Date:  1977-02

6.  Uptake and subcellular localization of daunorubicin and adriamycin in cultured fibroblasts.

Authors:  G Noel; C Peterson; A Trouet; P Tulkens
Journal:  Eur J Cancer       Date:  1978-04       Impact factor: 9.162

7.  Uptake of free and DNA-bound daunorubicin and doxorubicin into human leukemic cells.

Authors:  C Paul; C Peterson; G Gahrton; D Lockner
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

8.  Liquid chromatographic determination of daunorubicin and daunorubicinol in plasma from leukemic patients.

Authors:  S Eksborg; H Ehrsson; B Andersson; M Beran
Journal:  J Chromatogr       Date:  1978-06-01

9.  Daunomycin-induced cardiotoxicity in children and adults. A review of 110 cases.

Authors:  D D Von Hoff; M Rozencweig; M Layard; M Slavik; F M Muggia
Journal:  Am J Med       Date:  1977-02       Impact factor: 4.965

10.  The large-scale separation of peroxisomes, mitochondria, and lysosomes from the livers of rats injected with triton WR-1339. Improved isolation procedures, automated analysis, biochemical and morphological properties of fractions.

Authors:  F Leighton; B Poole; H Beaufay; P Baudhuin; J W Coffey; S Fowler; C De Duve
Journal:  J Cell Biol       Date:  1968-05       Impact factor: 10.539

View more
  2 in total

1.  DNA-binding parameters of daunorubicin and doxorubicin in the conditions used for studying the interaction of anthracycline-DNA complexes with cells in vitro.

Authors:  Y J Schneider; R Baurain; A Zenebergh; A Trouet
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

2.  Daunorubicin-DNA and doxorubicin-DNA. A review of experimental and clinical data.

Authors:  A Trouet; D Deprez-De Campeneere
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.